SCHEMBL13712962

SCHEMBL13712962

COC(=O)CC1CCN(C(=O)CC(C)(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.43
AOC2 O75106 1/20 0.41
ALDH1A1 P00352 2/20 0.40
BRD4 O60885 1/20 0.39
EPHX1 P07099 2/20 0.38
EPHX2 P34913 2/20 0.38
GPR119 Q8TDV5 1/20 0.38
DPP4 P27487 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
GLA P06280 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NAMPT P43490 1/20 0.36
RBP4 P02753 1/20 0.35
CYP3A4 P08684 1/20 0.35
JAK1 P23458 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9236069 0.80 KDM4E (0.48) ALDH1A1EPHX1EPHX2GPR119KDM4E
SCHEMBL18997634 0.79 FAAH (0.46) FAAHAOC2ALDH1A1GPR119DPP4
SCHEMBL13713534 0.79 EPHX2 (0.47) ALDH1A1BRD4EPHX1EPHX2GLA
SCHEMBL23136277 0.78 BRD4 (0.44) BRD4EPHX1EPHX2MAPT
SCHEMBL12384378 0.78 FAAH (0.47) FAAHAOC2ALDH1A1EPHX2GPR119
SCHEMBL13451999 0.78 FAAH (0.47) FAAHAOC2ALDH1A1EPHX2GPR119
SCHEMBL2210266 0.78 BRD4 (0.44) ALDH1A1BRD4EPHX1EPHX2SMN1; SMN2
SCHEMBL8790490 0.78 SMYD3 (0.48) ALDH1A1BRD4EPHX1EPHX2BCHE
SCHEMBL106242 0.78 KDM4E (0.52) FAAHALDH1A1EPHX1GPR119KDM4E
SCHEMBL18997635 0.77 FAAH (0.50) FAAHAOC2ALDH1A1GPR119KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592349-B2 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors IRM LLC (BM) 2009-09-22 US disclosed
US-20080139559-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139559-A1 DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS KIT, PRKCH, PRKCE FAAH 2709/4885AOC2 2503/4885ALDH1A1 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.